Seed Funding



Funded Projects Highlights

Suppression of tumor growth of malignant pleural mesothelioma

Usha Pendurthi, The University of Texas Health Center at Tyler

Project prepared high titer EPCR adenovirus and control G F P (green fluorescent protein) -adenoviruses. Funds used to perform 2 experiments over 30 days with 30 nude mice injected with cells of unmodified (native form of) REN cells. The suppression by EPCR adenovirus infection in this setting only gave a minimal and statistically insignificant advantage over control virus. Next steps include experimenting with a much larger number of mice for estimating the true significance of the EPCR mediated suppression and in a non-innate immunity inducing setting such as transferring the EPCR expression system into less immunogenic serovars of AAV virus (Adeno associated virus).

A technology to address vaccine cold-chain issues

Zhengrong Cui, Robert O. Williams III, The University of Texas at Austin

This innovative technology to manufacture aluminum salt-containing vaccines into a dosage form that is not sensitive to freezing has the potential reduce costly waste and the loss of nearly half of all global vaccine supplies. UT-Transform Seed Fund supports the inventors to conduct additional preclinical evaluations of their technology with two human vaccines licensed in the United States. Encouraging data from the preclinical evaluations using currently licensed human vaccines are expected to position the inventors to better pitch their technology and raise venture capital to accelerate their start-up.

Cloud based PBX

S. Venkatesan and Arulmani Sennimalai, The University of Texas at Dallas

The PBX (private branch exchange) market has been highly fragmented by proprietary systems. An open source initiative has been in development for a few years to change this to reduce acquisition cost and maintenance cost. This system, like the Unix operating system, is very difficult to use. In addition, large enterprises need high availability of their PBXs. This technology will make the system easy to use (by building an extensive graphic user interface, make the system manageable by the cloud so that product upgraded can be done automatically without any user input) and add high availability feature.

SmartShoes

Haiying Huang, The University of Texas at Arlington

UT TRANSFORM funds supported producing prototype of SmartShoes, shoes embedded with wireless sensors for measuring plantar shear and pressure forces during walking and intended for preventing foot ulcers for diabetic patients. The market potentials of the SmartShoes include a wearable assistive device that helps preventing foot ulcer in diabetic patients; and an effective clinical instrument for the study and understanding of skin ulceration.

Nanofiber Disposition Systems

Karen Lozano, The University of Texas-Pan American

UT TRANSFORM funds supported further development of a prototype for a hand held (portable) nanofiber making device, a technology envisioned to solve hemostasis related problems and burn care. A non-provisional patent was filed in December 2013 and licensing discussions are being held.

Voice Codex

Nigel Ward, The University of Texas at El Paso

Technology will help telecommunications systems transmit voice and video with more accuracy and reliability to the extent that it is more important. This means that systems should economize on the bits used to code less important moments in a conversation. The value for users equivalent will be perceived quality at lower cost. UTEP has filed a Patent Application, number 13/858,605, April 8, 2013, on this idea.

Skymesh

Author

Skymesh is designed and built to automate user's need to switch among clouds in order to use different functions kind of jobs securely and conveniently above the cloud. Cloud service providers (CSPs) store user data on their clouds but provide limited access to data owners. Skymesh will merge clouds together on a unified platform. A cloud-based operating system, we may call it, provides better experience, better functionality and better organization of the cloud.



Authors

Demonstrating SmartShoes for Real-time Shear and Pressure Sensing
Haiying Huang, The University of Texas at Arlington
Roller printed semiconductor nanomembranes for flexible RF electronics
Weidong Zhou, The University of Texas at Arlington
Commercialization of a New IP Process for Low cost, High Quality Micro Featured Glass Slides
John Priest, The University of Texas at Arlington
Multi-port dc power processor
Ali Davoudit, The University of Texas at Arlington
Edusex
Harry Lindner, The University of Texas at Austin
A New Technology to Address Critical Vaccine Cold-Chain Problems
Zhengrong Cui, The University of Texas at Austin
A New Technology to Address Critical Vaccine Cold-Chain Problems
Robert O. Williams III, The University of Texas at Austin
edMosphere: Giving students a voice
Lorna Hermosura, The University of Texas at Austin
Hoot.Me
Michael Koetting, The University of Texas at Austin
Panopticon
Cam Beasley, The University of Texas at Austin
Panopticon
Jason Phelps, The University of Texas at Austin
Panopticon
Sean Reid, The University of Texas at Austin
Panopticon
Daryl Ashley, The University of Texas at Austin
Development and characterization of bioactive and antimicrobial two-solution bone cements for orthopedic surgery
Danieli Rodrigues, The University of Texas at Dallas
Cloud based Hosted PBX
S. Venkatesan, The University of Texas at Dallas
Cloud based Hosted PBX
Arulmani Sennimalai, The University of Texas at Dallas
New Generation High-Performance Ultrananocrystalline Diamond(UNCD) Coated Dental Implants
Orlando Auciello, The University of Texas at Dallas
New Generation High-Performance Ultrananocrystalline Diamond(UNCD) Coated Dental Implants
Pablo Gurman, The University of Texas at Dallas
Super acoustic insulating hearing protection devices utilizing porous nanostructured polyurea
Hongbing Lu, The University of Texas at Dallas
Novel Fabrication of in situ Nanofiber based Hemostatic Treatments for Combat Wounds
Karen Lozano, The University of Texas-Pan American
Development of a Hybrid Streptococcal Protein Synthesis Screening Platform
James M. Bullard, The University of Texas-Pan American
Novel Treatment Product for Diabetic Patients
M. Vargas, The University of Texas at San Antonio
Novel Treatment Product for Diabetic Patients
Dr. Janakiram Seshu, The University of Texas at San Antonio
Cyanuric Acid removal from Sunlight-Exposed Swimming Pools
Noe Ortega, The University of Texas at El Paso
American Water Recycling
Eva Deemer, The University of Texas at El Paso
Morpheus: Smartphone Evidence-based Sleep Monitor and Apnea Detector
Homer Nazeran, The University of Texas at El Paso
Morpheus: Smartphone Evidence-based Sleep Monitor and Apnea Detector
Jose Ayala-Moyeda, The University of Texas at El Paso
Investigation of the immunogenic reaction to imprinted antibodies
Thomas Boland, The University of Texas at El Paso
Dynamic Control of Voice Codec Data Rate using Importance Estimation
Nigel Ward, The University of Texas at El Paso
Smart-phone evidence-based stress level monitor and mental fatigue detector
Homer Nazeran PhD, The University of Texas at El Paso
Smart-phone evidence-based stress level monitor and mental fatigue detector
Sergio Cabrera PhD, The University of Texas at El Paso
Suppression of tumor growth of malignant pleural mesothelioma
Usha Pendurthi, The University of Texas Health Center at Tyler
Proof-of-principle in vivo efficacy study of dengue antiviral drug candidate
Stan Watowich, The University of Texas Medical Branch
Flow Cytometry Remote Viewer with Decision Support
You-Wen Qian, The University of Texas Medical Branch
Molecular Match
Jim Welsh, The University of Texas M. D. Anderson Cancer Center
Mobile applications for prognostic staging systems
Simrit Parmar, The University of Texas M. D. Anderson Cancer Center
Mobile applications for prognostic staging systems
Srdan Verstovsek, The University of Texas M. D. Anderson Cancer Center
SynOsteo
Nowak Team, The University of Texas at San Antonio
Utilization of Metal-Assisted Etch in the Fabrication of Bioabsorbable Drug Eluting Stents.
Arturo Ayon, The University of Texas at San Antonio
This section is being updated with the most current information of the grant recipients (2/5/2014).

Background information about the seed funding part of the project

UT TRANSFORM provides up to $10,000 in seed funding for innovative commercialization projects in development from UT System institutions.

Process and rules for application for funding:

  1. The information provided by applicants is non-confidential.
  2. Factors that will be evaluated when considering applications include:
    1. Overall innovative idea
    2. Use of funds
    3. Commercial potential (total market size)
    4. Clear customer need
  3. Upon approval, applicants must complete an online entrepreneurship course (17 modules of about 30 to 60 minutes each) before receiving funds.
  4. Funded applicants must use the awarded funds as approved.
  5. Funded applicants must submit a written report of the progress of the project within two weeks of the completion date provided in the application. The report must include:
    1. Performance of the innovation (e.g., how well did the proof-of- concept work)
    2. Problems encountered
    3. Status of intellectual property (if any)
    4. Complementary and follow-on funding sought and/or received
    5. Status of commercialization (e.g., in start-up, licensed, …)
  6. The recipients are responsible for setting up accounts at the appropriate institutions according the guidelines of that institution (typically via an Office of Research Administration). The requirements for setting up accounts will vary from campus to campus. The funds will be transferred from UT Transform’s main account once the account has been properly set up and the recipients have successfully completed the UT Transform online education program.

To apply for seed funding, follow this link. Applications will be evaluated as they are submitted. Funds are limited, so earlier applications may have greater access to available funds.